Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo
about
Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli.In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.Variation in postantibiotic effect of clindamycin against clinical isolates of Staphylococcus aureus and implications for dosing of patients with osteomyelitis.Multiple-dose pharmacokinetics of amikacin and ceftazidime in critically ill patients with septic multiple-organ failure during intermittent hemofiltration.Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli.Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.Postantibiotic effects and Burkholderia (Pseudomonas) pseudomallei: evaluation of current treatment.Short-term topical therapy of experimental tinea pedis in guinea pigs with lanoconazole, a new imidazole antimycotic agent.Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum.Pharmacokinetics of imipenem in serum and skin window fluid in healthy adults after intramuscular or intravenous administration.A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections.In vivo and in vitro study of several pharmacodynamic effects of meropenem.Plasma pharmacokinetics and urine concentrations of meropenem in ewes.Drug detoxification dynamics explain the postantibiotic effect.Postantibiotic effects of imipenem and enoxacin against S. typhimurium and S. enteritidis and the influence on their surface hydrophobicity.In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin.Pharmacodynamic effects of meropenem on gram-negative bacteria.Post-antibiotic effect of beta-lactam antibiotics on gram-negative bacteria in relation to morphology, initial killing and MIC.
P2860
Q33690065-17E02148-4070-416F-BDD4-1526DDC761D1Q33981993-4C8E9F26-E11A-4322-AFDF-09AB927AE099Q35124885-6D3630B9-BBB5-42F1-B95C-9F63537C8F29Q35810241-1999F97F-4C2F-4071-884A-5A19B7298BC1Q35836760-120A062E-D0ED-4791-BF5E-2233CB42DF95Q35985436-A6ADD89E-B1E4-4636-9FCD-BAD941789D01Q39571043-C055A727-72D9-42D2-B88F-277ABA89C289Q39780685-AEDF9105-8BDE-4126-9DBC-E8A3495E6359Q39865931-A6E5CBAF-9742-4C46-94D5-72DD31BC1ABCQ39879629-42F07ED3-FFE9-4076-B8FF-6AF2D1440AABQ40131084-3F1BBD82-8A5C-4466-A181-691973FD07EFQ43771580-E9FD005A-A6A8-4197-8593-913A5123FA81Q44783360-EB3B7A44-9B1A-482E-8E12-118669195367Q44932110-0DFECEB7-2982-4FB2-B808-7AEA6F592DABQ50131272-D2909DFF-CF88-482E-8C84-214E6D55E064Q54165365-DE13A919-352D-4637-8372-18311146EC0DQ54613484-9904C23A-EFAA-4728-80BA-F0E0D510B4C6Q54689513-68831267-42E4-4723-A2C2-C09289239314
P2860
Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo
description
1989 nî lūn-bûn
@nan
1989 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo
@ast
Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo
@en
type
label
Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo
@ast
Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo
@en
prefLabel
Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo
@ast
Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo
@en
P2860
P356
P1476
Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo
@en
P2093
P2860
P304
P356
10.1128/AAC.33.10.1714
P407
P577
1989-10-01T00:00:00Z